Beta-O2 Technologies' Grant

Beta-O2 Technologies raised a round of funding on September 10, 2014. Investors include JDRF.

Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, the ├čAir. The company's flagship product is called the ├čAir Bio-artificial Pancreas. It is in developmen…

Articles about Beta-O2 Technologies' Grant: